complicated intra-abdominal infections

临床试验

计划入组 478 人 · 首次发布于 2005 年 9 月 21 日

已完成

NCT00229060

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

计划入组 483 人 · 首次发布于 2005 年 9 月 29 日

终止

NCT01381562

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

计划入组 15 人 · 首次发布于 2011 年 6 月 27 日

药物

查看全部 732 →

Small Molecule

Approved

Eravacycline(Xerava)

相关疾病：Intraabdominal Infections

C₂₇H₃₁FN₄O₈ · Rx

Small Molecule

Approved

Ceftolozane(Zerbaxa)

相关疾病：Nosocomial Pneumonia, Ventilator Associated Bacterial Pneumonia (VABP)，另有 3 项

C₂₃H₃₀N₁₂O₈S₂

Small Molecule

Approved

Avibactam(Avycaz, Zavicefta)

相关疾病：Bacterial Infections, Complicated Intra-Abdominal Infections (cIAIs)，另有 4 项

C₇H₁₁N₃O₆S · Rx

机构

查看全部 37 →

Intra-Cellular Therapies

United States

Intra-ImmuSG Pte Ltd

Singapore

INTRA-SANA LABORATORIES LLC

United States

资讯

查看全部 3786 →

去年

FDA Approves Novel Antibiotic Combination Emblaveo for Complex Abdominal Infections

2年前

EU Approves Pfizer's Emblaveo: First-in-Class Antibiotic for Multi-Drug Resistant Infections

去年

临床试验

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

药物

Eravacycline(Xerava)

Ceftolozane(Zerbaxa)

Avibactam(Avycaz, Zavicefta)

机构

Intra-Cellular Therapies

Intra-ImmuSG Pte Ltd

INTRA-SANA LABORATORIES LLC

资讯

FDA Approves Novel Antibiotic Combination Emblaveo for Complex Abdominal Infections

EU Approves Pfizer's Emblaveo: First-in-Class Antibiotic for Multi-Drug Resistant Infections

Complicated Urinary Tract Infection Pipeline Shows Robust Development with 12+ Companies Advancing Novel Therapies